U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632469) titled 'mGFR vs tGFR in AKI' on June 02.
Brief Summary: The goal of this study is to learn if the TGFR device (which uses telmapirazin to continuously measure real-time GFR) works to provide accurate and dynamic kidney function assessment in critically ill adults with acute kidney injury (AKI). It will also learn how tGFR compares with the gold standard measured GFR (mGFR) and other commonly used estimate methods. The main questions it aims to answer are:
* Does tGFR show good agreement with mGFR over the 0-12 hour period in AKI patients?
* How do tGFR, mGFR, 4-hour creatinine clearance, kinetic GFR (keGFR), and CKD-EPI eGFR compare across...